Other languages Royalty Pharma plc

Equities

RPRX

GB00BMVP7Y09

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
27.27 ^USD	-2.19%		-2.92%	-2.92%

May. 16	Transcript : Royalty Pharma plc Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM
May. 14	Transcript : Royalty Pharma plc Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 09:00 AM

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading	May. 09
Royalty Pharma to Acquire Frexalimab Royalties, Milestones for $525 Million in Cash	May. 09
Royalty Pharma's Q1 Net Income, Revenue Falls	May. 09
Royalty Pharma plc Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Arrowhead Nets $50 Milestone Payment from Royalty Pharma After Completion of Enrollment in Trial of Cardiovascular Drug	May. 03
Royalty Pharma plc Declares Dividend for the Second Quarter of 2024, Payable on June 14, 2024	Apr. 17
Royalty Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15
Royalty Pharma Swings to Q4 Net Income, Revenue Increases	Feb. 15
Royalty Pharma plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15
Novartis will Morphosys schlucken - Zugriff auf Hoffnungsträger	Feb. 06
Royalty Pharma plc Declares Dividend for the First Quarter of 2024, Payable on March 15, 2024	Jan. 19
Royalty Pharma Insider Sold Shares Worth $13,222,862, According to a Recent SEC Filing	Jan. 04
PureTech Health Provides Updates on Programs, Reports Strong Financial Position	Dec. 20
Morphosys besorgt sich mit Kapitalerhöhung mehr als 100 Millionen Euro	Dec. 14
Morphosys besorgt sich mit Kapitalerhöhung mehr als 100 Millionen Euro	Dec. 14
MORPHOSYS IM FOKUS: Der erschütterte Glaube an einen Kassenschlager	Nov. 22
MedinCell : collaboration entre Teva et Royalty Pharma	Nov. 13
Teva Pharmaceuticals International GmbH and Royalty Pharma plc Collaborate to Further Accelerate Olanzapine LAI Program	Nov. 13
Sector Update: Health Care Stocks Advance Premarket Wednesday	Nov. 08
Sector Update: Health Care	Nov. 08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Royalty Pharma plc

Equities

RPRX

GB00BMVP7Y09

Other languages

Filters